Impact of Persistent Somatic Mutations on Day 14 After Induction Chemotherapy for Acute Myeloid Leukemia

Residual AML on D14 after induction typically warrants re-induction. This decision is based on D14 cellularity and blast count, yet many with aplastic D14 marrows fail to achieve CR.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Kendra Sweet, Mohammad Hussaini, Jeffrey Lancet, Rami Komrokji, Alan List, Lynn Moscinski, Jinming Song, Eric Padron Source Type: research